J Physiol Society Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 564, Number 1, 21-31, April 1, 2005 DOI: 10.1113/jphysiol.2004.081646
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
564/1/21    most recent
jphysiol.2004.081646v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukuda, K.
Right arrow Articles by Balser, J. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukuda, K.
Right arrow Articles by Balser, J. R

Compound-specific Na+ channel pore conformational changes induced by local anaesthetics

Koji Fukuda1, Tadashi Nakajima1, Prakash C Viswanathan1 and Jeffrey R Balser1,2

Departments of
1 Anaesthesiology
2 Pharmacology, Vanderbilt University, School of Medicine, Nashville, TN 37232, USA

Upon prolonged depolarizations, voltage-dependent Na+ channels open and subsequently inactivate, occupying fast and slow inactivated conformational states. Like C-type inactivation in K+ channels, slow inactivation is thought to be accompanied by rearrangement of the channel pore. Cysteine-labelling studies have shown that lidocaine, a local anaesthetic (LA) that elicits depolarization-dependent (‘use-dependent’) Na+ channel block, does not slow recovery from fast inactivation, but modulates the kinetics of slow inactivated states. While these observations suggest LA-induced stabilization of slow inactivation could be partly responsible for use dependence, a more stringent test would require that slow inactivation gating track the distinct use-dependent kinetic properties of diverse LA compounds, such as lidocaine and bupivacaine. For this purpose, we assayed the slow inactivation-dependent accessibility of cysteines engineered into domain III, P-segment (µ1: F1236C, K1237C) to sulfhydryl (MTSEA) modification using a high-speed solution exchange system. As expected, we found that bupivacaine, like lidocaine, protected cysteine residues from MTSEA modification in a depolarization-dependent manner. However, under pulse-train conditions where bupivacaine block of Na+ channels was extensive (due to ultra-slow recovery), but lidocaine block of Na+ channels was not, P-segment cysteines were protected from MTSEA modification. Here we show that conformational changes associated with slow inactivation track the vastly different rates of recovery from use-dependent block for bupivacaine and lidocaine. Our findings suggest that LA compounds may produce their kinetically distinct voltage-dependent behaviour by modulating slow inactivation gating to varying degrees.

(Received 17 December 2004; accepted after revision 24 January 2005; first published online 27 January 2005)
Corresponding author P. C. Viswanathan: 560, Preston Research Building, 2220 Pierce Avenue, Vanderbilt University School of Medicine, Nashville, TN 37232-6602, USA. Email: prakash.viswanathan{at}vanderbilt.edu




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
P. L. Sheets, C. Heers, T. Stoehr, and T. R. Cummins
Differential Block of Sensory Neuronal Voltage-Gated Sodium Channels by Lacosamide [(2R)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide], Lidocaine, and Carbamazepine
J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 89 - 99.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. Ouyang, T.-Y. Jih, T.-T. Zhang, A. M. Correa, and H. C. Hemmings Jr.
Isoflurane Inhibits NaChBac, a Prokaryotic Voltage-Gated Sodium Channel
J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1076 - 1083.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. E. Clancy, Z. I. Zhu, and Y. Rudy
Pharmacogenetics and anti-arrhythmic drug therapy: a theoretical investigation
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H66 - H75.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 The Physiological Society.